# Molecular Signatures of Cutaneous Squamous Cell Carcinoma During Recessive Dystrophic Epidermolysis Bullosa

> **NCT04285294** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 66 (estimated)

## Conditions studied

- Recessive Dystrophic Epidermolysis Bullosa

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04285294
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2020-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04285294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04285294, "Molecular Signatures of Cutaneous Squamous Cell Carcinoma During Recessive Dystrophic Epidermolysis Bullosa". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04285294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*